Publication
Title
Postbiotics in the medical field under the perspective of the ISAPP definition : scientific, regulatory, and marketing considerations
Author
Abstract
Diverse terms have been used in the literature to refer to the health benefits obtained from the administration of non-viable microorganisms or their cell fragments and metabolites. In an effort to provide continuity to this emerging field, the International Scientific Association of Probiotics and Prebiotics (ISAPP) convened a panel of experts to consider this category of substances and adopted the term postbiotic, which they defined as a "preparation of inanimate microorganisms and/or their components that confers a health benefit on the host." This definition does not stipulate any specific health benefit, finished product, target population or regulatory status. In this perspective article, we focused on postbiotics developed for pharmaceutical uses, including medicinal products and medical devices. We address how this field is regulated for products based on inanimate microorganisms, marketing considerations and existing examples of postbiotics products developed as cosmetics for the skin, for vaginal health, and as orally consumed products. We focus on the European Union for regulatory aspects, but also give examples from other geographical areas.
Language
English
Source (journal)
Frontiers in pharmacology. - [Lausanne, 2010, currens
Publication
[Lausanne : Frontiers Media] , 2023
ISSN
1663-9812
DOI
10.3389/FPHAR.2023.1239745
Volume/pages
14 (2023) , p. 1-6
Article Reference
1239745
ISI
001068253800001
Pubmed ID
37745060
Medium
E-only publicatie
Full text (Publisher's DOI)
Full text (open access)
UAntwerpen
Faculty/Department
Research group
Publication type
Subject
Affiliation
Publications with a UAntwerp address
External links
Web of Science
Record
Identifier
Creation 02.10.2023
Last edited 25.04.2024
To cite this reference